A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis

Published:2015-11-09 Issue:12 Volume:45 Page:1260-1269
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Müller-Deile Janina¹,Schiffer Lena¹,Hiss Marcus¹,Haller Hermann¹,Schiffer Mario¹

Affiliation:

1. Division of Nephrology and Hypertension; Department of Medicine; Hannover Medical School; Hannover Germany

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12545/fullpdf

Reference43 articles.

1. Scottish renal biopsy registry membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian population;McQuarrie;Nephrol Dial Transplant,2010

2. The changing pattern of adult primary glomerular disease;Hanko;Nephrol Dial Transplant,2009

3. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey;Glassock;Am J Kidney Dis,2010

4. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy;Kuroki;Intern Med,2002

5. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy;Ohtani;Nephrol Dial Transplant,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membranous nephropathy: pathogenesis and treatments;MedComm;2024-06-29

2. Therapeutic plasmapheresis in idiopathic membranous nephropathy anti‐PLA2R‐related: A case series;Journal of Clinical Apheresis;2024-06

3. Low Dose Rituximab and Calcineurin Inhibitor Combination as an Effective Treatment Strategy in Relapsed Primary Membranous Nephropathy;2024-05-30

4. Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature Review;Journal of Personalized Medicine;2024-02-26

5. Membranous nephropathy treatment standard;Nephrology Dialysis Transplantation;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3